This inventor holds 2 USPTO granted patents. Top assignee: Medinnova Sf. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Jarle Breivik: Innovator in Oncogene Detection
Introduction
Jarle Breivik is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of molecular biology, particularly in the detection of oncogenes. With a total of 2 patents to his name, Breivik's work has the potential to impact cancer research and diagnostics.
Latest Patents
One of his latest patents is a method for the detection of Ras oncogenes, specifically the K-ras gene. This innovative approach involves the isolation of nucleic acid, which is crucial for understanding the genetic factors involved in cancer.
Career Highlights
Breivik is currently associated with Medinnova SF, a company that focuses on advancing medical technologies. His work at Medinnova SF has allowed him to explore new methodologies in cancer detection and treatment.
Collaborations
Throughout his career, Breivik has collaborated with esteemed colleagues such as Gustav Gaudernack and Anne Spurkland. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Jarle Breivik's contributions to oncogene detection exemplify the importance of innovation in medical research. His patents and collaborations continue to pave the way for advancements in cancer diagnostics and treatment.